Skip to main content
Equibles

FIFTH THIRD BANCORP

Bank

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 35527 CINCINNATI, OH
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$888,404
+$635,421 QoQ
Shares Held
60,190
+0.6% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 192 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIFTH THIRD BANCORP holds $202,001,766 across 150 Biotechnology names. SLS ranks #37 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 81,898 $40,681,193
2 REGN
Regeneron Pharmaceuticals, Inc.
 29,244 $18,234,803
3 TECH
BIO-TECHNE Corp
 117,371 $8,292,261
4 VCEL
Vericel Corp
 185,051 $8,232,918
5 KYMR
Kymera Therapeutics, Inc.
 65,659 $7,529,117
6 HALO
Halozyme Therapeutics, Inc.
 95,681 $7,488,951
7 BBIO
BridgeBio Pharma, Inc.
 87,238 $6,497,486
8 RARE
Ultragenyx Pharmaceutical Inc.
 193,236 $6,452,150

All Filings in SLS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $888,404 60,190
2026-03-31 $252,983 59,807